Investigating the Mechanism of IFN-γ-Inducible Lysosomal Thiol Reductase-Mediated Inhibition of Breast Cancer Cell ProliferationOA
Investigating the Mechanism of IFN-γ-Inducible Lysosomal Thiol Reductase-Mediated Inhibition of Breast Cancer Cell Proliferation
Qin Liu;Jingwei Zhang;Yihao Tian;Lei Wei;Xiaoning Yuan;Youcheng Shao;Xiaoqing Guan;Kaixiang Feng;Mengfei Chu;Le Chen;Hui Li;Hanhui Liu
Department of Pathology and Pathophysiology,Hubei Provincial Key Laboratory of Developmentally Originated Disease,TaiKang Medical School(School of Basic Medical Sciences),Wuhan University,Wuhan,Hubei,ChinaDepartment of Breast and Thyroid Surgery,Zhongnan Hospital of Wuhan University,Hubei Key Laboratory of Tumor Biological Behaviors,Hubei Cancer Clinical Study Center,Wuhan,Hubei,ChinaDepartment of Human Anatomy,TaiKang Medical School(School of Basic Medical Sciences),Wuhan University,Wuhan,Hubei,ChinaDepartment of Pathology and Pathophysiology,Hubei Provincial Key Laboratory of Developmentally Originated Disease,TaiKang Medical School(School of Basic Medical Sciences),Wuhan University,Wuhan,Hubei,ChinaDepartment of Pathology and Pathophysiology,Hubei Provincial Key Laboratory of Developmentally Originated Disease,TaiKang Medical School(School of Basic Medical Sciences),Wuhan University,Wuhan,Hubei,ChinaDepartment of Pathology and Pathophysiology,Hubei Provincial Key Laboratory of Developmentally Originated Disease,TaiKang Medical School(School of Basic Medical Sciences),Wuhan University,Wuhan,Hubei,ChinaDepartment of Pathology and Pathophysiology,Hubei Provincial Key Laboratory of Developmentally Originated Disease,TaiKang Medical School(School of Basic Medical Sciences),Wuhan University,Wuhan,Hubei,ChinaDepartment of Breast and Thyroid Surgery,Zhongnan Hospital of Wuhan University,Hubei Key Laboratory of Tumor Biological Behaviors,Hubei Cancer Clinical Study Center,Wuhan,Hubei,ChinaDepartment of Human Anatomy,TaiKang Medical School(School of Basic Medical Sciences),Wuhan University,Wuhan,Hubei,ChinaDepartment of Pathology and Pathophysiology,Hubei Provincial Key Laboratory of Developmentally Originated Disease,TaiKang Medical School(School of Basic Medical Sciences),Wuhan University,Wuhan,Hubei,ChinaDepartment of Pathology and Pathophysiology,Hubei Provincial Key Laboratory of Developmentally Originated Disease,TaiKang Medical School(School of Basic Medical Sciences),Wuhan University,Wuhan,Hubei,ChinaDepartment of Pathology and Pathophysiology,Hubei Provincial Key Laboratory of Developmentally Originated Disease,TaiKang Medical School(School of Basic Medical Sciences),Wuhan University,Wuhan,Hubei,China
breast cancerIFN-γ-inducible lysosomal thiol reductaseMYCOICR-9429WDR5
breast cancerIFN-γ-inducible lysosomal thiol reductaseMYCOICR-9429WDR5
《肿瘤学创新（英文）》 2025 (2)
30-41,12
Fundamental Research Funds for the Central Universities(Grant No:2042022FK1209)National Natural Science Funds of China(Grant No:81972833)Basic and Clinical Medical Research Joint Fund of Zhongnan Hospital of Wuhan University(Grant No:JCZN2022008).
评论